{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:03:24Z","timestamp":1761581004331,"version":"3.44.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health NINDS","doi-asserted-by":"crossref","award":["#5 RO1 NS40778"],"award-info":[{"award-number":["#5 RO1 NS40778"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001340","name":"WW Smith Charitable Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001340","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jneuroim.2012.06.007","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T09:00:30Z","timestamp":1341478830000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: The Guided Missile strategy"],"prefix":"10.1016","volume":"251","author":[{"given":"W.","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.N.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Miagkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-S.","family":"Juon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.B.","family":"Drachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.06.007_bb0005","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.4049\/jimmunol.163.10.5303","article-title":"Dendritic cells are resistant to apoptosis through the Fas (CD95\/APO-1) pathway","volume":"163","author":"Ashany","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.21630","article-title":"Opportunistic infections and other risks with newer multiple sclerosis therapies","volume":"65","author":"Berger","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1634\/stemcells.22-6-908","article-title":"Fas ligand as a tool for immunosuppression and generation of immune tolerance","volume":"22","author":"Bohana-Kashtan","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0025","article-title":"Optimized protocol for efficient transfection of dendritic cells without maturation","volume":"53","author":"Bowles","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0030","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1172\/JCI113807","article-title":"In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes","volume":"82","author":"Brocke","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/vim.2004.17.327","article-title":"Adenoviral vectors for gene replacement therapy","volume":"17","author":"Cao","year":"2004","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0040","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1016\/S0021-9258(18)68370-X","article-title":"Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1. Sequence similarity to proteins bearing onco\u2010differentiation antigens","volume":"263","author":"Chen","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0045","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.4049\/jimmunol.136.7.2437","article-title":"Immunotherapy for myasthenia gravis: a murine model","volume":"136","author":"Christadoss","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0050","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"Cole","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1749-6632.1998.tb10936.x","article-title":"T cell recognition of the acetylcholine receptor in myasthenia gravis","volume":"841","author":"Conti-Fine","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0060","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0065","first-page":"251","article-title":"Therapy of myasthenia gravis","volume":"vol. 3rd Series","author":"Drachman","year":"2008"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jnnp.43.7.601","article-title":"Mechanisms of acetylcholine receptor loss in myasthenia gravis","volume":"43","author":"Drachman","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0075","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.1073\/pnas.90.21.10340","article-title":"The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr\/lpr","volume":"90","author":"Drappa","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0080","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.gt.3302597","article-title":"Gutted adenovirus: a rising star on the horizon?","volume":"12","author":"Ehrhardt","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0003-9861(73)90462-1","article-title":"Purification and molecular properties of the acetylcholine receptor from Torpedo electroplax","volume":"159","author":"Eldefrawi","year":"1973","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0090","series-title":"Current Topics in Nerve and Muscle Research","first-page":"111","article-title":"The ultrastructural localization of the acetylcholine receptor, immunoglobulin G and the third and ninth complement components at the motor endplate and their implications for the pathogenesis of myasthenia gravis","author":"Engel","year":"1979"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc14c01s00","article-title":"Human adenoviruses: propagation, purification, quantification, and storage","author":"Green","year":"2006","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0105","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0021-9258(18)53945-4","article-title":"The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1","volume":"268","author":"Guarnieri","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.20.100301.064828","article-title":"Antigen presentation and T cell stimulation by dendritic cells","volume":"20","author":"Guermonprez","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI113369","article-title":"Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis","volume":"81","author":"Hohlfeld","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0125","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.4049\/jimmunol.170.11.5406","article-title":"Mature, but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from fas-mediated apoptosis and can be used as killer APC","volume":"170","author":"Hoves","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1078\/0171-2985-00293","article-title":"Elimination of activated but not resting primary human CD4+ and CD8+ cells by Fas ligand (FasL\/CD95L)-expressing killer-dendritic cells","volume":"208","author":"Hoves","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0307s86","article-title":"Isolation of dendritic cells","author":"Inaba","year":"2009","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-61779-346-2_14","article-title":"Human dendritic cell culture and bacterial infection","volume":"799","author":"Jones","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2008.06.010","article-title":"Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis","volume":"201\u2013202","author":"Jung","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.850793","article-title":"Myasthenic immunoglobulin accelerates acetylcholine receptor degradation","volume":"196","author":"Kao","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0155","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.152.6.3152","article-title":"Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis","volume":"152","author":"Kaul","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","article-title":"Mature T lymphocyte apoptosis\u2010immune regulation in a dynamic and unpredictable antigenic environment","volume":"17","author":"Lenardo","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1749-6632.1976.tb47693.x","article-title":"Experimental autoimmune myasthenia gravis: cellular and humoral immune responses","volume":"274","author":"Lennon","year":"1976","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0170","series-title":"Myasthenia Gravis and Myasthenic Disorders","first-page":"111","article-title":"Experimental autoimmune myasthenia gravis: induction and treatment","author":"Lindstrom","year":"1999"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0175","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0180","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/1521-4141(200207)32:7<2055::AID-IMMU2055>3.0.CO;2-Q","article-title":"T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor","volume":"32","author":"Lobito","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-5728(92)90092-Y","article-title":"Tolerance to acetylcholine receptor induced by AChR-coupled syngeneic cells","volume":"38","author":"McIntosh","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0165-5728(98)00071-X","article-title":"Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein","volume":"87","author":"McIntosh","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.410310314","article-title":"T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha\u2010subunit","volume":"31","author":"Melms","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1089\/1044549041562311","article-title":"Gene transfer of baculoviral p35 by adenoviral vector protects human cerebral neurons from apoptosis","volume":"23","author":"Miagkov","year":"2004","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt0498-364","article-title":"Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA","volume":"16","author":"Nair","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0896-8411(89)90121-2","article-title":"T-cell reactivity in myasthenia gravis","volume":"2","author":"Newsom-Davis","year":"1989","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-6632.1998.tb10931.x","article-title":"Immune regulation and myasthenia gravis","volume":"841","author":"Ragheb","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10616-011-9375-4","article-title":"Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6","volume":"63","author":"Ramadan","year":"2011","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1212\/WNL.29.3.291","article-title":"Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site","volume":"29","author":"Richman","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virol.2010.06.050","article-title":"Immunization of neonatal mice with LAMP\/p55 HIV gag DNA elicits robust immune responses that last to adulthood","volume":"406","author":"Rigato","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3181\/00379727-132-34264","article-title":"Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb\/c mice to soluble and particulate immunogen","volume":"132","author":"Rittenberg","year":"1969","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0240","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.155.4.1818","article-title":"Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal\/lysosomal compartment enhances its presentation to MHC class II-restricted T cells","volume":"155","author":"Rowell","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0245","first-page":"A418","article-title":"Muscle specific tyrosine kinase (MuSK) positive, seronegative myasthenia gravis (SN-MG). Clinical characteristics and response to therapy","volume":"Suppl. 1","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0250","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/imt.10.26","article-title":"Killer artificial antigen-presenting cells: the synthetic embodiment of a \u2018guided missile\u2019","volume":"2","author":"Schutz","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0255","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.2741\/e211","article-title":"Pluripotent stem cell-derived dendritic cells for immunotherapy","volume":"2","author":"Senju","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0260","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1749-6632.1988.tb27161.x","article-title":"Specific suppression of the antibody response to acetylcholine receptor in vitro and in vivo by daunomycin-acetylcholine receptor conjugates","volume":"540","author":"Shelton","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0265","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/82712","article-title":"The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity","volume":"1","author":"Siegel","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-065X.2010.00917.x","article-title":"The power and the promise of restimulation-induced cell death in human immune diseases","volume":"236","author":"Snow","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0275","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.134.2.841","article-title":"Experimental autoimmune myasthenia gravis: can pretreatment with 125I\u2010labeled receptor prevent functional damage at the neuromuscular junction?","volume":"134","author":"Sterz","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJM197701202960301","article-title":"Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice","volume":"296","author":"Toyka","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0290","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1016\/j.vaccine.2009.05.093","article-title":"Comparison of DNA vaccines producing HIV-1 Gag and LAMP\/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes","volume":"27","author":"Valentin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0295","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0300","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.50.4.1045","article-title":"T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis","volume":"50","author":"Wang","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0305","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0310","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0092-8674(89)90786-1","article-title":"T cell recognition as the target for immune intervention in autoimmune disease","volume":"57","author":"Wraith","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0315","first-page":"15.8.1","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"vol. 3, Suppl. 21","author":"Wu","year":"1997"},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0320","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.4049\/jimmunol.166.7.4773","article-title":"Specific immunotherapy by genetically engineered APCs: the \u201cguided missile\u201d strategy","volume":"166","author":"Wu","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0325","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/cimm.2001.1778","article-title":"Specific immunotherapy of experimental myasthenia gravis in vitro: the \u201cguided missile\u201d strategy","volume":"208","author":"Wu","year":"2001","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/clin.1997.4451","article-title":"How subtle differences in MHC class II affect the severity of experimental myasthenia gravis","volume":"86","author":"Yang","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-5728(87)90028-2","article-title":"Influence of T cell specificity on the heterogeneity and disease\u2010causing capability of antibody against the acetylcholine receptor","volume":"17","author":"Yeh","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.06.007_bb0340","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/3488","article-title":"Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells","volume":"16","author":"Zhang","year":"1998","journal-title":"Nat. Biotechnol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:34Z","timestamp":1759047574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812001907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":68,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0165572812001907"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.06.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: The Guided Missile strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}